TBI-1301

· Takara Bio Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TBI-1301, covering 2024-11-20 to 2025-12-03. Get the full timeline:

Most recent: Clinical Trial Update: Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid Tumors [Phase 1]

See pricing